TNF-α-Mediated Expression of the Receptor for Anaphylatoxin C5a on Neurons in Experimental Listeria Meningoencephalitis

Journal of Immunology

Volumn 159, Issue 2, 1997, Pages 861-869

  Stahel, Philip F ^a   Frei, Karl ^c   Eugster, Hans Pietro ^c   Fontana, Adriano ^c   Hummel, Klaus M ^b   Wetsel, Rick A ^d   Ames, Robert S ^e   Barnum, Scott R ^a  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^e GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5A RECEPTOR; COMPLEMENT RECEPTOR; LEUKOCYTE ANTIGEN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BIOSYNTHESIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; LISTERIOSIS; MENINGOENCEPHALITIS; METABOLISM; MOUSE; NERVE CELL;

ANIMALS; ANTIGENS, CD; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LISTERIA INFECTIONS; MENINGOENCEPHALITIS; MICE; MICE, INBRED ICR; NEURONS; RECEPTOR, ANAPHYLATOXIN C5A; RECEPTORS, COMPLEMENT; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031570894     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Durand, M. L., S. B. Calderwood, D. J. Weber, S. I. Miller, F. S. Southwick, V. S. Caviness, Jr., and M. N. Swartz. 1993. Acute bacterial meningitis in adults: a review of 493 episodes. N. Engl. J. Med. 328:21.
2. Waage, A., A. Halstensen, R. Shalaby, P. Brandtzaeg, P. Kierulf, and T. Espevik. 1989. Local production of tumor necrosis factor α, interleukin 1, and interleukin 6 in meningococcal meningitis: relation to the inflammatory response. J. Exp. Med. 170:1859.
3. Ramilo, O., X. Saez-Llorens, J. Mertsola, H. Jafari, K. D. Olsen, E. J. Hansen, M. Yoshinaga, S. Ohkawara, H. Nariuchi, and G. H. McCracken, Jr. 1990. Tumor necrosis factor α/cachectin and interleukin 1β initiate meningeal inflammation. J. Exp. Med. 172:497.
4. Saukkonen, K., S. Sande, C. Cioffe, S. Wolpe, B. Sherry, A. Cerami, and E. Tuomanen. 1990. The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis. J. Exp. Med. 171:439.
5. Quagliarello, V. J., B. Wispeley, W. J. Long, Jr., and W. M. Scheld. 1991. Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. J. Clin. Invest. 87:1360.
6. Pfister, H.-W., A. Fontana, M. G. Täuber, A. Tomasz, and W. M. Scheld. 1994. Mechanisms of brain injury in bacterial meningitis: workshop summary. Clin. Infect. Dis. 19:463.
7. Ködel, U., A. Bernatowicz, R. Paul, K. Frei, A. Fontana, and H.-W. Pfister. 1995. Experimental pneumococcal meningitis: cerebrovascular alterations, brain edema, and meningeal inflammation are linked to the production of nitric oxide. Ann. Neurol. 37:313.
8. Mustafa, M. M., O. Ramilo, K. D. Olsen, P. S. Franklin, E. J. Hansen, B. Beutler, and G. H. McCracken, Jr. 1989. Tumor necrosis factor in mediating experimental Haemophilus influenzae type B meningitis. J. Clin. Invest. 84:1253.
9. Leist, T. P., K. Frei, S. Kam-Hansen, R. M. Zinkernagel, and A. Fontana. 1988. Tumor necrosis factor or in cerebrospinal fluid during bacterial but not viral meningitis: evaluation in murine model infection and in patients. J. Exp. Med. 167:1743.
10. Nadal, D., D. Leppert, K. Frei, P. Gallo, H. Lamche, and A. Fontana. 1989. Tumor necrosis factor-α in infectious meningitis. Arch. Dis. Child. 64:1274.
11. Frei, K., D. Nadal, and A. Fontana. 1990. Intracerebral synthesis of tumor necrosis factor-α and interleukin-6 in infectious meningitis. Ann. NY Acad. Sci. 594:326.
12. Täuber, M., U. Borschberg, and M. A. Sande. 1988. Influence of granulocytes on brain edema, intracranial pressure, and cerebrospinal fluid concentrations of lactate and protein in experimental meningitis. J. Infect. Dis. 157:456.
13. Tuomanen, E. I., K. Saukkonen, S. Sande, C. Cioffe, and S. D. Wright. 1989. Reduction of inflammation, tissue damage, and mortality in bacterial meningitis in rabbits treated with monoclonal antibodies against adhesion-promoting receptors of leukocytes. J. Exp. Med. 170:959.
14. Saez-Llorens, X., H. S. Jafari, C. Severien, F. Parras, K. D. Olsen, E. J. Hansen, I. I. Singer, and G. H. McCracken, Jr. 1991. Enhanced attenuation of meningeal inflammation and brain edema by concomitant administration of anti-CD18 monoclonal antibodies and dexamethasone in experimental haemophilus meningitis. J. Clin. Invest. 88:2003.
15. Quagliarello, V., and W. M. Scheld. 1992. Bacterial meningitis: pathogenesis, pathophysiology, and progress. N. Engl. J. Med. 327:864.
16. Tang, T., P. S. Frenette, R. O. Hynes, D. D. Wagner, and T. N. Mayadas. 1996. Cytokine-induced meningitis is dramatically attenuated in mice deficient in endothelial selectins. J. Clin. Invest. 97:2485.
17. Ernst, J. D., K. T. Hartiala, I. M. Goldstein, and A. M. Sande. 1984. Complement (C5)-derived chemotactic activity accounts for accumulation of polymorphonuclear leukocytes in cerebrospinal fluid of rabbits with pneumococcal meningitis. Infect. Immun. 46:81.
18. Tuomanen, E., B. Hengstler, O. Zak, and A. Tomasz. 1986. The role of complement in inflammation during experimental pneumococcal meningitis. Microb. Pathog. 1:15.
19. Kadurugamuwa, J. L., B. Hengstler, M. A. Bray, and O. Zak. 1989. Inhibition of complement-factor-5a-induced inflammatory reactions by prostaglandin E2 in experimental meningitis. J. Infect. Dis. 160:715.
20. Faustmann, P. M., D. Krause, R. Dux, and R. Dermietzel. 1995. Morphological study in the early stages of complement C5a fragment-induced experimental meningitis: activation of macrophages and astrocytes. Acta Neuropathol. 89:239.
21. Goodman, M. G., D. E. Chenoweth, and W. O. Weigle. 1982. Induction of interleukin-1 secretion and enhancement of humoral immunity by binding of human C5a to macrophage surface C5a receptors. J. Exp. Med. 1156:912.
22. Okusawa, S., C. A. Dinarello, K. B. Yancey, S. Endres, T. J. Lawley, M. M. Frank, J. F. Burke, and J. A. Gelfand. 1987. C5a induction of human interleukin 1: synergistic effect with endotoxin or interferon-γ. J. Immunol. 139:2635.
23. Okusawa, S., K. B. Yancey, J. W. M. Van der Meer, S. Endres, G. Lonnemann, K. Hefter, M. M. Frank, J. F. Burke, C. A. Dinarello, and J. A. Gelfand. 1988. C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro: comparison with secretion of interleukin 1β and interleukin 1α. J. Exp. Med. 168:443.
24. Scholz, W., M. R. McClurg, G. J. Cardenas, M. Smith, D. J. Noonan, T. E. Hugli, and E. L. Morgan. 1990. C5a-mediated release of interleukin 6 by human monocytes. Clin. Immunol. Immunopathol. 57:297.
25. Ember, J. A., S. D. Sanderson, T. E. Hugli, and E. L. Morgan. 1994. Induction of interleukin-8 synthesis from monocytes by human C5a anaphylatoxin. Am. J. Pathol. 144:393.
26. Andersson, P.-B., V. H. Perry, and S. Gordon. 1992. Intracerebral injection of proinflammatory cytokines or leukocyte chemotaxins induces minimal myelomonocytic cell recruitment to the parenchyma of the central nervous system. J. Exp. Med. 176:255.
27. Gerard, C., and N. P. Gerard. 1994. C5a anaphylatoxin and its seven transmembrane-segment receptor. Annu. Rev. Immunol. 12:775.
28. Murphy, P. M. 1994. The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immunol. 12:593.
29. Wetsel, R. A. 1995. Structure, function and cellular expression of complement anaphylatoxin receptors. Curr. Opin. Immunol. 7:48.
30. Foreman, K. E., A. A. Vaporciyan, B. K. Bonish, M. L. Jones, K. J. Johnson, M. M. Glovsky, S. M. Eddy, and P. A. Ward. 1994. C5a-induced expression of P-selectin in endothelial cells. J. Clin. Invest. 94:1147.
31. Haviland, D. L., R. L. McCoy, W. T. Whitehead, H. Akama, E. P. Molmenti, A. Brown, J. C. Haviland, W. C. Parks, D. H. Permutter, and R. A. Wetsel. 1995. Expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on non-myeloid cells of the liver and lung. J. Immunol. 154:1861.
32. Lacy, M., J. Jones, S. R. Whittemore, D. L. Haviland, R. A. Wetsel, and S. R. Barnum. 1995. Expression of the receptors for the C5a anaphylatoxin, interleukin-8 and FMLP by human astrocytes and microglia. J. Neuroimmunol. 61:71.
33. Gasque, P., P. Chan, M. Fontaine, A. Ischenko, M. Lamacz, O. Götze, and B. P. Morgan. 1995. Identification and characterization of the complement C5a anaphylatoxin receptor on human astrocytes. J. Immunol. 155:4882.
34. Müller-Ladner, U., J. L. Jones, R. A. Wetsel, S. Gay, C. S. Raine, and S. R. Barnum. 1996. Enhanced expression of chemotactic receptors in multiple sclerosis lesions. J. Neurol. Sci. 144:135.
35. Eugster, H.-P., M. Müller, U. Karrer, B. D. Car, B. Schnyder, V. M. Eng, G. Woerly, M. Le Hir, F. di Padova, M. Aguet, R. Zinkernagel, H. Bluethmann, and B. Ryffel. 1996. Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-α double-deficient mice. Int. Immunol. 8:23.
36. Gerard, C., L. Bao, O. Orozco, M. Pearson, D. Kunz, and N. P. Gerard. 1992. Structural diversity in the extracellular faces of peptidergic G-protein-coupled receptors: molecular cloning of the mouse C5a anaphylatoxin receptor. J. Immunol. 149:2600.
37. Ames, R. S., M. A. Tornetta, C. S. Jones, and P. Tsui. 1994. Isolation of neutralizing anti-C5a monoclonal antibodies from a filamentous phage monovalent Fab display library. J. Immunol. 152:4572.
38. Roth, J., P. Saremaslani, M. J. Warhol, and P. U. Heitz. 1992. Improved accuracy in diagnostic immunohistochemistry, lectin histochemistry and in situ hybridization using a gold-labeled horseradish peroxidase antibody and silver intensification. Lab. Invest. 67:263.
39. Kriegsmann, J., G. M. Keyszer, T. Geiler, R. Braeuer, R. E. Gay, and S. Gay. 1995. Expression of vascular cell adhesion molecule-1 mRNA and protein in rheumatoid synovium demonstrated by in situ hybridization and immunohistochemistry. Lab. Invest. 72:209.
40. Seebach, J., D. Bartholdi, K. Frei, K.-S. Spanaus, E. Ferrero, U. Widmer, S. Isenmann, R. M. Strieter, M. Schwab, H.-W. Pfister, and A. Fontana. 1995. Experimental Listeria meningoencephalitis: macrophage inflammatory protein-1α and -2 are produced intrathecally and mediate chemotactic activity in cerebrospinal fluid of infected mice. J. Immunol. 155:4367.
41. Xia, M., S. Qin, M. McNamara, and B. T. Hyman. 1996. Type B IL-8 receptor (IL-8RB) in neuritic plaques of Alzheimer's disease. J. Neuropathol. Exp. Neurol. 55:619 (Abstr.).
42. Gutierrez, E. G., W. A. Banks, and A. J. Kastin. 1993. Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J. Neuroimmunol. 47:169.
43. Lieberman, A. P., P. M. Pitha, H. S. Shin, and M. L. Shin. 1989. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc. Natl Acad. Sci. USA 116:6348.
44. Frei, K., C. Siepl, P. Groscurth, S. Bodmer, C. Schwerdel, and A. Fontana. 1987. Antigen presentation and tumor cytotoxicity by interferon-γ-treated microglial cells. Eur. J. Immunol. 17:1271.
45. Tchelingerian, J.-L., J. Quinonero, J. Booss, and C. Jacque. 1993. Localization of TNFα and IL-1α immunoreactivities in striatal neurons after surgical injury to the hippocampus. Neuron 10:213.
46. Liu, T., R. K. Clark, P. C. McDonnell, P. R. Young, R. F. White, F. C. Barone, and G. Z. Feuerstein. 1994. Tumor necrosis factor-a expression in ischemic neurons. Stroke 25:1481.
47. Frei, K., and A. Fontana. 1989. Immune regulatory functions of astrocytes and microglial cells within the central nervous system. In Neuroimmune Networks: Physiology and Diseases. E. J. Goetzl and N. H. Spector, eds. A. R. Liss, New York, p. 127.
48. Southwick, F. S., and D. L. Purich. 1996. Intracellular pathogenesis of Listeriosis. N. Engl. J. Med. 334:770.
49. Peters, M., and M. Hewicker-Trautwein. 1994. Infection of murine fetal brain cell cultures with Listeria monocytogenes. Vet. Microbiol. 41:19.
50. Ming, W. J., L. Bersani, and A. Mantovani. 1987. Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes. J. Immunol. 138:1469.
51. Spanaus, K.-S., D. Nadal, H.-W. Pfister, J. Seebach, U. Widmer, K. Frei, S. Gloor, and A. Fontana. 1997. C-X-C and C-C chemokines are expressed in the cerebrospinal fluid in bacterial meningitis and mediate chemotactic activity on peripheral blood-derived polymorphonuclear and mononuclear cells in vitro. J. Immunol. 158:1956.
52. Hugli, T. E. 1981. The structural basis for anaphylatoxin and chemotaxic function of C3a, C4a and C5a. Crit. Rev. Immunol. 1:321.
53. McCoy, R., D. L. Haviland, E. P. Molmenti, T. Ziambaras, R. A. Wetsel, and D. H. Perlmutter. 1995. N-formylpeptide and complement C5a receptors are expressed in liver cells and mediate hepatic acute phase gene regulation. J. Exp. Med. 182:207.
54. Höpken, U. E., B. Lu, N. P. Gerard, and C. Gerard. 1996. The C5a chemoattractant receptor mediates mucosal defence to infection. Nature 383:86.
55. Armstrong, R. C., L. Harvath, and M. E. Dubois-Dalcq. 1990. Type 1 astrocytes and oligodendrocyte-type 2 astrocyte glial progenitors migrate toward distinct molecules. J. Neurosci. Res. 27:400.
56. Yao, J., L. Harvath, D. L. Gilbert, and C. A. Colton. 1990. Chemotaxis by a CNS macrophage, the microglia. J. Neurosci. Res. 27:36.
57. Williams, C. A., N. Schupf, and T. E. Hugli. 1985. Anaphylatoxin C5a modulation of an alpha-adrenergic receptor system in the rat hypothalamus. J. Neuroimmunol 9:29.
58. Zwahlen, A., U. E. Nydegger, P. Vaudaux, P.-H. Lambert, and F. A. Waldvogel. 1982. Complement-mediated opsonic activity in normal and infected human cerebrospinal fluid: early response during bacterial meningitis. J. Infect. Dis. 145:635.
59. Barnum, S. R. 1995. Complement biosynthesis in the central nervous system. Crit. Rev. Oral Biol. Med. 6:132.
60. Hartung, H.-P., C. Schwenke, D. Bitter-Suermann, and K. V. Toyka. 1987. Guillain-Barré syndrome: activated complement components C3a and C5a in CSF. Neurology 37:1006.